Bridgeway Capital Management, LLC Harpoon Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.55 - $0.82 $6,600 - $9,840	-12,000 Reduced 12.0%	88,000 $62,000
Q1 2023 May 15, 2023	BUY	$0.65 - $1.37 $32,500 - $68,500	50,000 Added 100.0%	100,000 $74,000
Q4 2022 Feb 14, 2023	SELL	$0.6 - $1.41 $2,640 - $6,204	-4,400 Reduced 8.09%	50,000 $36,000
Q2 2022 Aug 15, 2022	SELL	$1.78 - $5.02 $74,512 - $210,142	-41,861 Reduced 43.49%	54,400 $104,000
Q1 2022 May 16, 2022	BUY	$3.54 - $8.08 $340,763 - $777,788	96,261 New	96,261 $478,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.